secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K/A
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0001213900-24-048040
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX files APT financials: net loss $16M, going concern doubt
--------------------------------------------------------------

- APT net loss of $16.0M in 2023 and $23.6M in 2022; accumulated deficit $67.3M at Dec 31, 2023.
- APT revenue $14.1M in 2023 vs $5.9M in 2022 from government grants; cash only $1.3M.
- Auditor's report includes going concern emphasis; current cash insufficient for 12 months.
- APT issued $12.0M of Series B-1 preferred in 2023 but needs additional financing.
- Financials filed to complete previously reported acquisition of APT by BiomX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390024048040/0001213900-24-048040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390024048040/ea0207019-8ka1_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-048040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer